These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2547 related articles for article (PubMed ID: 28522654)

  • 1. Diabetic Kidney Disease: Challenges, Progress, and Possibilities.
    Alicic RZ; Rooney MT; Tuttle KR
    Clin J Am Soc Nephrol; 2017 Dec; 12(12):2032-2045. PubMed ID: 28522654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis.
    Hung PH; Hsu YC; Chen TH; Lin CL
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    J Nephrol; 2020 Feb; 33(1):9-35. PubMed ID: 31576500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid decline of renal function in patients with type 2 diabetes with heavy proteinuria: a report of three cases.
    Lim CTS; Nordin NZ; Fadhlina NZ; Anim MS; Kalaiselvam T; Haikal WZ; Goh BL
    BMC Nephrol; 2019 Jan; 20(1):22. PubMed ID: 30651084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updating the natural history of diabetic nephropathy.
    Pugliese G
    Acta Diabetol; 2014 Dec; 51(6):905-15. PubMed ID: 25297841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
    De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
    Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy.
    Rabkin R
    Clin Cornerstone; 2003; 5(2):1-11. PubMed ID: 12800476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
    Castellino P; Shohat J; DeFronzo RA
    Semin Nephrol; 1990 May; 10(3):228-41. PubMed ID: 2190280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and diabetic kidney disease.
    Maric-Bilkan C
    Med Clin North Am; 2013 Jan; 97(1):59-74. PubMed ID: 23290730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities.
    Aboolian A; Urner S; Roden M; Jha JC; Jandeleit-Dahm K
    Handb Exp Pharmacol; 2022; 274():269-307. PubMed ID: 35318511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of de novo allograft diabetic nephropathy in renal allograft recipients.
    Prasad N; Gupta P; Jain M; Bhadauria D; Gupta A; Sharma RK; Kaul A
    Exp Clin Transplant; 2013 Jun; 11(3):215-21. PubMed ID: 23767942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and management of diabetic nephropathy].
    Kitada M; Koya D
    Nihon Rinsho; 2015 Dec; 73(12):2037-43. PubMed ID: 26666150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Nephropathy: An Overview.
    Sagoo MK; Gnudi L
    Methods Mol Biol; 2020; 2067():3-7. PubMed ID: 31701441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Yamanouchi M; Skupien J; Niewczas MA; Smiles AM; Doria A; Stanton RC; Galecki AT; Duffin KL; Pullen N; Breyer MD; Bonventre JV; Warram JH; Krolewski AS
    Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of type 2 diabetes management strategies on renal risk factors.
    Muskiet MH; Tonneijck L; Smits MM; Kramer MH; Heerspink HJ; van Raalte DH
    Lancet Diabetes Endocrinol; 2015 May; 3(5):367-81. PubMed ID: 25943756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline.
    Krolewski AS; Bonventre JV
    Semin Nephrol; 2012 Sep; 32(5):407-14. PubMed ID: 23062980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.
    Slaughter TN; Paige A; Spires D; Kojima N; Kyle PB; Garrett MR; Roman RJ; Williams JM
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R727-34. PubMed ID: 23926133
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 128.